glp-1 news today october 2025 obesity drug therapies are changing care. What does WHO recommend? Here's what you need to know obesity drug news today october – GLP-1 Indications Continue to Expand:

This Policy also describes your choices about the collection and use of your information

Legault C, Maki PM, Resnick SM, Coker L, Hogan P, Bevers TB, et al

Compounded GLP-1s have not been evaluated by the FDA, but side effects are expected to be similar to other GLP-1-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)

(Source 3) 6

Besides maintaining normal acetylcholine levels, several studies indicate other neuroprotective benefits of acetyl-L-